Raphael Ognar
Co-founder,
NKILT Therapeutics
Sessions
-
02-Sep-2025Panel: Beyond capital - What biotech’s need from investors
-
04-Sep-2025Spotlight: Unlocking off-the-shelf potential for cancer patients: building scalable, accessible and fit-for-purpose cell therapy
-
04-Sep-2025Theatre 1: Panel: Charting the way forward: Where are we heading?
-
09-Feb-2026Indigo Ballroom, Hilton Bayfront HotelThe commercial blind spot - Bridging the business gap for scientific founders
-
10-Feb-2026Phacilitate.TV StudioNKILT Therapeutics: next gen cell therapy to more cancer patients
-
10-Feb-2026Theatre 4Creating successful academic-industry collaborations
-
10-Feb-2026Innovation ZoneThe Promise of scalable, affordable & profitable, off-the-shelf cell therapy to Help >50% of cancer patients achieve long-lasting remission
-
09-Sep-2026Theatre 1Spotlight: Off-the-shelf is working: Now what has to change to scale it responsibly?